Statistics for Tight control with adalimumab-based treatment is associated with improved quality of life outcomes in patients with moderate to severely active Crohn-s disease: data from CALM
Total visits
| views | |
|---|---|
| Tight control with adalimumab-based treatment is associated with improved quality of life outcomes in patients with moderate to severely active Crohn-s disease: data from CALM | 0 |
Total visits per month
| views | |
|---|---|
| November 2023 | 0 |
| December 2023 | 0 |
| January 2024 | 0 |
| February 2024 | 0 |
| March 2024 | 0 |
| April 2024 | 0 |
| May 2024 | 0 |